|
MnSOD Mimetic BMX-001 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: BMX-001, Manganese (III) ortho N-Butoxyethylpyridylporphyrin, Manganese Butoxyethyl Pyridyl Porphyrin, Mitochondrial Manganese Superoxide Dismutatse Mimetic BMX-001, Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin, MnTnBuOE-3-PyP 5+
Gilbert, Arizona1 trial
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Arizona Center for Cancer Care - Gilbert
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.